When building your watch list, look for stocks with an 80 or higher RS Rating. BioNTech ADR just met that criteria with a new score of 82.
Looking For The Best Stocks To Buy And Watch? Start Here
IBD's proprietary RS Rating measures market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the last 52 weeks matches up against other publicly traded companies.
History reveals that the best-performing stocks typically have an RS Rating north of 80 as they launch their biggest price moves.
BioNTech ADR is trying to complete a consolidation with a 131.49 entry. See if it can break out in heavy trade.
The company showed 0% EPS growth last quarter. Sales increased 123%.
BioNTech ADR earns the No. 143 rank among its peers in the Medical-Biomed/Biotech industry group. Aurinia Pharmaceuticals, Halozyme Therapeutics and Incyte are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Biotech And Pharmaceutical Industry And Stock News
Stocks With Rising Relative Strength Ratings
